EBF1 nuclear repositioning instructs chromatin refolding to promote therapy resistance in T leukemic cells.

Abstract

Chromatin misfolding has been implicated in cancer pathogenesis; yet, its role in therapy resistance remains unclear. Here, we systematically integrated sequencing and imaging data to examine the spatial and linear chromatin structures in targeted therapy-sensitive and -resistant human T cell acute lymphoblastic leukemia (T-ALL). We found widespread alterations in successive layers of chromatin organization including spatial compartments, contact domain boundaries, and enhancer positioning upon the emergence of targeted therapy resistance. The reorganization of genome folding structures closely coincides with the restructuring of chromatin activity and redistribution of architectural proteins. Mechanistically, the derepression and repositioning of the B-lineage-determining transcription factor EBF1 from the heterochromatic nuclear envelope to the euchromatic interior instructs widespread genome refolding and promotes therapy resistance in leukemic T cells. Together, our findings suggest that lineage-determining transcription factors can instruct changes in genome topology as a driving force for epigenetic adaptations in targeted therapy resistance.

• Authors: Yeqiao Zhou, Jelena Petrovic, Jingru Zhao, Wu Zhang, Ashkan Bigdeli, Zhen Zhang, Shelley L Berger, Warren S Pear, Robert B Faryabi
• Journal: Molecular cell (Mol Cell) Vol. 82 Issue 5 Pg. 1003-1020.e15 (03 03 2022) ISSN: 1097-4164 [Electronic] United States
• PMID: 35182476 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2022 Elsevier Inc. All rights reserved.

Chemical References

• Chromatin
• EBF1 protein, human
• Trans-Activators
• Transcription Factors

Topics

• Chromatin (genetics)
• Drug Repositioning
• Humans
• Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (drug therapy, genetics)
• T-Lymphocytes (metabolism)
• Trans-Activators (genetics, metabolism)
• Transcription Factors (genetics, metabolism)